Apixaban API has been approved by China NMPA
02/11/2021
One step further with Apixaban. We are happy to announce that Apixaban API has been approved by China NMPA.
馃帀馃帀 This is a significant milestone for our company. Really great job from our regulatory, intellectual property, manufacturing and business development departments based in Malta, Spain and China!
Do you want to get more information? Contact聽us;聽product@medichem.es; or if you prefer, meet us in person next week!聽at stand 14F70 in the聽#cphi2021
